Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/77859
Title: Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Authors: Bin Zhou
Rodrigo M. Carrillo-Larco
Goodarz Danaei
Leanne M. Riley
Christopher J. Paciorek
Gretchen A. Stevens
Edward W. Gregg
James E. Bennett
Bethlehem Solomon
Rosie K. Singleton
Marisa K. Sophiea
Maria L.C. Iurilli
Victor P.F. Lhoste
Melanie J. Cowan
Stefan Savin
Mark Woodward
Yulia Balanova
Renata Cifkova
Albertino Damasceno
Paul Elliott
Farshad Farzadfar
Jiang He
Nayu Ikeda
Andre P. Kengne
Young Ho Khang
Hyeon Chang Kim
Avula Laxmaiah
Hsien Ho Lin
Paula Margozzini Maira
J. Jaime Miranda
Hannelore Neuhauser
Johan Sundström
Cherian Varghese
Indah S. Widyahening
Tomasz Zdrojewski
Majid Ezzati
Leandra Abarca-Gómez
Ziad A. Abdeen
Hanan F. Abdul Rahim
Niveen M. Abu-Rmeileh
Benjamin Acosta-Cazares
Robert J. Adams
Wichai Aekplakorn
Kaosar Afsana
Shoaib Afzal
Imelda A. Agdeppa
Javad Aghazadeh-Attari
Carlos A. Aguilar-Salinas
Charles Agyemang
Noor Ani Ahmad
Ali Ahmadi
Naser Ahmadi
Nastaran Ahmadi
Fariba Ahmadizar
Soheir H. Ahmed
Wolfgang Ahrens
Kamel Ajlouni
Rajaa Al-Raddadi
Monira Alarouj
Fadia AlBuhairan
Shahla AlDhukair
Mohamed M. Ali
Abdullah Alkandari
Ala’a Alkerwi
Kristine Allin
Eman Aly
Deepak N. Amarapurkar
Norbert Amougou
Philippe Amouyel
Lars Bo Andersen
Sigmund A. Anderssen
Ranjit Mohan Anjana
Alireza Ansari-Moghaddam
Daniel Ansong
Hajer Aounallah-Skhiri
Joana Araújo
Inger Ariansen
Tahir Aris
Raphael E. Arku
Nimmathota Arlappa
Krishna K. Aryal
Thor Aspelund
Felix K. Assah
Maria Cecília F. Assunção
Juha Auvinen
Mária Avdićová
Ana Azevedo
Mohsen Azimi-Nezhad
Fereidoun Azizi
Mehrdad Azmin
Bontha V. Babu
Suhad Bahijri
Nagalla Balakrishna
Mohamed Bamoshmoosh
Maciej Banach
Maja Banadinović
Piotr Bandosz
José R. Banegas
Joanna Baran
Carlo M. Barbagallo
Éco-anthropologie
Dasman Diabetes Institute
Leibniz Institute for Prevention Research and Epidemiology
Western Norway University of Applied Sciences
Neyshabur University of Medical Sciences
Université de Lille
Caja Costarricense de Seguro Social
King Saud bin Abdulaziz University for Health Sciences
Qatar University
Birzeit University
Universidade Eduardo Mondlane
Luxembourg Institute of Health
Kwame Nkrumah University of Science and Technology
Food and Nutrition Research Institute Manila
Universidad Peruana Cayetano Heredia
Haskoli Islands
Université de Yaoundé I
Universitas Indonesia
Harvard T.H. Chan School of Public Health
Erasmus MC
Al-Quds University
Københavns Universitet
Zahedan University of Medical Sciences
Pontificia Universidad Católica de Chile
South African Medical Research Council
UNSW Sydney
Organisation Mondiale de la Santé
Universidad Autónoma de Madrid
Indian Council of Medical Research
University of California, Berkeley
Urmia University of Medical Sciences
Flinders University
University of Ghana
CHU Lille
Università degli Studi di Palermo
Tulane University
Faculdade de Medicina da Universidade do Porto (FMUP)
Yonsei University
Oulu University Hospital
Charles University
Robert Koch Institut
Copenhagen University Hospital
Imperial College London
Universidade Federal de Pelotas
University of Massachusetts Amherst
University of Oulu
Kementerian Kesihatan Malaysia
Mahidol University
Gdanski Uniwersytet Medyczny
Norwegian Institute of Public Health
Bombay Hospital and Medical Research Centre
Universitetet i Oslo
Instituto Nacional de la Nutrición Salvador Zubiran
BRAC University
Instituto Mexicano del Seguro Social
Shahid Sadoughi University of Medical Sciences
University of Rzeszów
Universidade do Porto
Frederiksberg Hospital
Medical University of Lodz
University of Zagreb School of Medicine
National Institute of Biomedical Innovation
National Taiwan University
King Abdulaziz University
Norges idrettshøgskole
Uppsala Universitet
Universiteit van Amsterdam
Seoul National University College of Medicine
Madras Diabetes Research Foundation
ICMR-National Institute of Nutrition
Non-Communicable Diseases Research Center
University of Science and Technology
Modeling in the Health Research Center
Research Institute for Endocrine Sciences
Abt Associates
Natl. Preventive Medicine Res. Ctr.
Aldara Hospital and Medical Center
Regional Authority of Public Health in Banska Bystrica
National Center for Diabetes
National Institute of Public Health
Thomayer Hospital
WHO Regional Office for the Eastern Mediterranean
Keywords: Medicine
Issue Date: 11-Sep-2021
Citation: The Lancet. Vol.398, No.10304 (2021), 957-980
Abstract: Background: Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. Methods: We used data from 1990 to 2019 on people aged 30–79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. Findings: The number of people aged 30–79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306–359) million women and 317 (292–344) million men in 1990 to 626 (584–668) million women and 652 (604–698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55–62) of women and 49% (46–52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43–51) of women and 38% (35–41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20–27) for women and 18% (16–21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. Interpretation: Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings. Funding: WHO.
URI: http://repository.li.mahidol.ac.th/dspace/handle/123456789/77859
metadata.dc.identifier.url: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85114679906&origin=inward
ISSN: 1474547X
01406736
Appears in Collections:Scopus 2021

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.